Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barnaby Nelson

Showing results (241-250 of 311) with videos related to

Pageof 32
Sort By:
BMJ Open|December 25, 2025
Can a digital intervention 'Momentum' improve social functioning and transdiagnostic symptoms for Australian youth at ultrahigh risk for psychosis? Protocol for a superiority randomised controlled trial comparing treatment as usual with and without MomentumShaminka N Mangelsdorf, Daniela Cagliarini, Barnaby Nelson, et al.
Schizophrenia Research. Cognition|October 13, 2025
Premorbid functioning trajectories and the one-year course of cognitive performance in first-episode psychosis: a cluster analysis in PSYSCANMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
International Review of Psychiatry (Abingdon, England)|November 28, 2025
Early intervention for psychiatry itself: the invisible hands for future psychiatryEric Y H Chen, Stephanie M Y Wong, Jimmy Lee, et al.
JAMA Psychiatry|September 20, 2023
Network-Based Spreading of Gray Matter Changes Across Different Stages of PsychosisSidhant Chopra, Ashlea Segal, Stuart Oldham, et al.
Psychiatry and Clinical Neurosciences|April 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high riskLucy A Chester, Lucia R Valmaggia, Matthew J Kempton, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Psychological Medicine|January 5, 2024
The temporal association between social isolation, distress, and psychotic experiences in individuals at clinical high-risk for psychosisZeynep Akcaoglu, Thomas Vaessen, Eva Velthorst, et al.
Frontiers in Psychiatry|June 30, 2020
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
JAMA Psychiatry|June 28, 2023
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized TrialPatrick D McGorry, Cristina Mei, G Paul Amminger, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Pageof 32

Showing results (241-250 of 311) with videos related to

Sort By:
Pageof 32
BMJ Open|December 25, 2025
Can a digital intervention 'Momentum' improve social functioning and transdiagnostic symptoms for Australian youth at ultrahigh risk for psychosis? Protocol for a superiority randomised controlled trial comparing treatment as usual with and without MomentumShaminka N Mangelsdorf, Daniela Cagliarini, Barnaby Nelson, et al.
Schizophrenia Research. Cognition|October 13, 2025
Premorbid functioning trajectories and the one-year course of cognitive performance in first-episode psychosis: a cluster analysis in PSYSCANMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
International Review of Psychiatry (Abingdon, England)|November 28, 2025
Early intervention for psychiatry itself: the invisible hands for future psychiatryEric Y H Chen, Stephanie M Y Wong, Jimmy Lee, et al.
JAMA Psychiatry|September 20, 2023
Network-Based Spreading of Gray Matter Changes Across Different Stages of PsychosisSidhant Chopra, Ashlea Segal, Stuart Oldham, et al.
Psychiatry and Clinical Neurosciences|April 18, 2023
Influence of cannabis use on incidence of psychosis in people at clinical high riskLucy A Chester, Lucia R Valmaggia, Matthew J Kempton, et al.
Schizophrenia Bulletin Open|August 15, 2024
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention TrialBarnaby Nelson, Hok Pan Yuen, G Paul Amminger, et al.
Psychological Medicine|January 5, 2024
The temporal association between social isolation, distress, and psychotic experiences in individuals at clinical high-risk for psychosisZeynep Akcaoglu, Thomas Vaessen, Eva Velthorst, et al.
Frontiers in Psychiatry|June 30, 2020
Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
JAMA Psychiatry|June 28, 2023
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized TrialPatrick D McGorry, Cristina Mei, G Paul Amminger, et al.
Frontiers in Psychiatry|June 28, 2019
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical TrialMaximus Berger, Barnaby Nelson, Connie Markulev, et al.
Pageof 32